8-K
filed December 13, 2022, 6:59 PM ET
ticker MDT
CIK 0001613103
other
confidence high
sentiment neutral
materiality 0.10
Medtronic shareholders elect all 11 director nominees, approve all proposals at 2022 AGM
Medtronic plc
- Each of 11 director nominees elected with 90-99% of votes cast (excluding broker non-votes).
- Ratification of PwC as independent auditor for FY2023 passed with 92.2% of votes cast.
- Advisory say-on-pay approved with 92.7% of votes cast (ex. broker non-votes).
- Authority to issue shares, opt out of pre-emption, and overseas share purchases all approved with >97% support.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Medtronic plc shareholders approved Advisory vote on named executive officer compensation at the 2022-12-08 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2022-12-08
Exact text from the filing
3. The shareholders approved, on a non-binding advisory basis, the compensation awarded to the Company’s named executive officers. FOR AGAINST ABSTAIN BROKER NON-VOTE 972,415,707 69,940,489 2,116,068 115,948,969
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Medtronic plc shareholders approved Authorization of overseas market purchases of Medtronic ordinary shares by Company and subsidiaries at the 2022-12-08 meeting.
- Outcome
- passed
- Meeting
- 2022-12-08
Exact text from the filing
6. The shareholders approved authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. FOR AGAINST ABSTAIN 1,129,189,149 27,068,953 4,163,131
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Medtronic plc shareholders approved Renewal of Board's authority to issue shares at the 2022-12-08 meeting.
- Outcome
- passed
- Meeting
- 2022-12-08
Exact text from the filing
4. The shareholders approved renewal of the Board’s authority to issue shares. FOR AGAINST ABSTAIN 1,146,144,000 11,969,471 2,307,762
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Medtronic plc shareholders approved Ratify appointment of PricewaterhouseCoopers LLP as independent auditor and authorize Board to set remuneration at the 2022-12-08 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-12-08
Exact text from the filing
2. The shareholders ratified, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal year 2023 and authorized, in a binding vote, the Company’s Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration. FOR AGAINST ABSTAIN 1,069,480,945 89,379,651 1,560,637
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Medtronic plc shareholders approved Election of eleven directors to hold office until 2023 Annual General Meeting at the 2022-12-08 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-12-08
Exact text from the filing
1. The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2023 Annual General Meeting of the Company and until his or her successor is elected, as follows: FOR AGAINST ABSTAIN BROKER NON-VOTE Richard H. Anderson 982,165,958 61,475,254 831,052 115,948,969 Craig Arnold 1,006,424,719 28,982,687 9,064,858 115,948,969 Scott C. Donnelly 1,023,458,233 20,095,049 918,982 115,948,969 Lidia L. Fonseca 1,027,825,711 15,881,098 765,455 115,948,969 Andrea J. Goldsmith, Ph.D. 1,040,386,088 3,158,654 927,522 115,948,969 Randall J. Hogan, III 1,034,757,456 8,853,730 861,078 115,948,969 Kevin E. Lofton 1,040,312,283 3,322,096 837,885 115,948,969 Geoffrey S. Martha 966,120,676 71,626,975 6,724,613 115,948,969 Elizabeth G. Nabel, M.D. 910,568,825 133,144,537 758,902 115,948,969 Denise M. O’Leary 953,636,260 89,936,614 899,390 115,948,969 Kendall J. Powell 939,339,071 104,313,760 819,433 115,948,969
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Medtronic plc shareholders approved Renewal of Board's authority to opt out of pre-emption rights at the 2022-12-08 meeting.
- Outcome
- passed
- Meeting
- 2022-12-08
Exact text from the filing
5. The shareholders approved renewal of the Board’s authority to opt out of pre-emption rights. FOR AGAINST ABSTAIN 1,136,000,204 21,877,612 2,543,417
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.